Indian Immunologicals Limited
- All
- News
-
Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine
Vaccine manufacturer Indian Immunologicals Limited (IIL) signed a Memorandum of Association (MoA) with the Indian Council of Medical Research (ICMR) for the clinical development of the Zika vaccine.
-
Indian Immunologicals Targets Dengue Vaccine Launch By January 2026
Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country's first such vaccine heats up.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
-
Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine
Vaccine manufacturer Indian Immunologicals Limited (IIL) signed a Memorandum of Association (MoA) with the Indian Council of Medical Research (ICMR) for the clinical development of the Zika vaccine.
-
Indian Immunologicals Targets Dengue Vaccine Launch By January 2026
Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the country's first such vaccine heats up.
-
PSU Gets Loan License To Supply Covaxin Drug Substance To Bharat Biotech
Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech Covaxin drug substance produced at its repurposed facility, the Department of Biotechnology (DBT) said on Friday.
